- Home
- ACRS vs CRGO Comparison
ACRS vs CRGO Comparison
Compare ACRS & CRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRS
- CRGO
- Stock Information
- Founded
- ACRS 2012
- CRGO 2012
- Country
- ACRS United States
- CRGO Spain
- Employees
- ACRS N/A
- CRGO N/A
- Industry
- ACRS Biotechnology: Pharmaceutical Preparations
- CRGO Blank Checks
- Sector
- ACRS Health Care
- CRGO Finance
- Exchange
- ACRS Nasdaq
- CRGO Nasdaq
- Market Cap
- ACRS 230.8M
- CRGO 195.4M
- IPO Year
- ACRS 2015
- CRGO N/A
- Fundamental
- Price
- ACRS $2.85
- CRGO $3.26
- Analyst Decision
- ACRS Strong Buy
- CRGO
- Analyst Count
- ACRS 5
- CRGO 0
- Target Price
- ACRS $9.75
- CRGO N/A
- AVG Volume (30 Days)
- ACRS 1.4M
- CRGO 98.8K
- Earning Date
- ACRS 11-06-2025
- CRGO 11-17-2025
- Dividend Yield
- ACRS N/A
- CRGO N/A
- EPS Growth
- ACRS N/A
- CRGO N/A
- EPS
- ACRS N/A
- CRGO N/A
- Revenue
- ACRS $15,742,000.00
- CRGO $28,642,000.00
- Revenue This Year
- ACRS N/A
- CRGO $27.63
- Revenue Next Year
- ACRS N/A
- CRGO $24.42
- P/E Ratio
- ACRS N/A
- CRGO N/A
- Revenue Growth
- ACRS N/A
- CRGO 27.55
- 52 Week Low
- ACRS $1.05
- CRGO $1.72
- 52 Week High
- ACRS $4.24
- CRGO $4.42
- Technical
- Relative Strength Index (RSI)
- ACRS 67.71
- CRGO 46.54
- Support Level
- ACRS $2.34
- CRGO $2.80
- Resistance Level
- ACRS $2.57
- CRGO $3.24
- Average True Range (ATR)
- ACRS 0.22
- CRGO 0.29
- MACD
- ACRS 0.03
- CRGO -0.06
- Stochastic Oscillator
- ACRS 96.18
- CRGO 33.33
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.